Screening Patients for Clinical Trials with Genome Analysis

Intel’s Ben Crisman explains how genome analysis can assist with screening patients for clinical trials through a demo of a high-performance, cost-effective solution from QIAGEN running on the Intel® Scalable System Framework at Supercomputing 2016.

Please visit intel.co.uk/healthcare/optimizecode for more information.